This activity is jointly sponsored/co-provided by Global Medical Education and Postgraduate Institute for Medicine.
This activity is supported in part by an independent education grant from Sunovion Pharmaceuticals.
Specialty: Psychiatric Medicine
Release date: June 6, 2014
Valid through: June 30, 2015
This activity has been designed to meet the educational needs of physicians, PCP's, NP's, PA's, nurses involved in the care of patients with bipolar depression.
An efficacious long term therapy for bipolar depression remains one of the great unmet needs in the care of patients with bipolar disorder.
Clinicians need to consider not just the short term risk benefit ratio of the currently available efficacious treatments when choosing one for their patients but also long term adverse effects including weight gain, metabolic disturbances and cognitive effects. Of the three FDA approved treatments for bipolar depression there are differences in the side effect profiles which may affect clinician choice.
This program consists of 2 continuing education activites.